Table 2
Passive permeability, active transport, and visual acuity in eyes with succesfull photocoagulation—that is, without CSMO at follow up (n = 23, responding eyes) and eyes where CSMO was still present at follow up (n = 23, non-responding eyes). For comparison, data from eyes without CSMO both at baseline and follow up (n=11) are included
| Passive permeability nm/s baseline/follow up | Active transport nm/s baseline/follow up | Visual acuity logMAR baseline/follow up | |
|---|---|---|---|
| *Significant difference (t test) between responding and non-responding eyes at follow up. †Significant differences (t test) between eyes without CSMO and both groups of CSMO eyes (that is, both responding and non-responding eyes). ‡The significant difference between eyes without CSMO and non-responding eyes with persistent CSMO at follow up. | |||
| CSMO at baseline no CSMO at follow up | |||
| Mean | 8.23/7.44* | 66.82/63.07 | 0.08/0.05* |
| 95% confidence interval | 5.5 to 12/5.1 to 11 | 42 to 107/43 to 93 | 0.02 to 0.14/0.01 to 0.09 |
| CSMO at baseline still CSMO at follow up | |||
| Mean | 12.26/13.49 | 67.53/95.15 | 0.18/0.33 |
| 95% confidence interval | 8.4 to 18/9.5 to 19 | 54 to 112/72 to 125 | 0.07 to 0.30/0.21 to 0.46 |
| No CSMO at baseline and follow up | |||
| Mean | 3.67†/3.95‡ | 86.78/85.66 | 0.04/0.04‡ |
| 95% confidence interval | 2.6 to 5.1/2.7 to 5.9 | 63 to 119/60 to 121 | −0.1 to 1.7/−0.08 to 1.7 |
